Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
Transgene Biotek Share Price
Transgene Biotek Share ...
Transgene Biotek share price insights
Company has posted a profit of Rs 0.2 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)
Stock gave a 3 year return of 139.78% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
Company's annual revenue growth of 80.33% outperformed its 3 year CAGR of -1.6%. (Source: Consolidated Financials)
Transgene Biotek Ltd. share price moved down by -0.22% from its previous close of Rs 8.70. Transgene Biotek Ltd. stock last traded price is 8.68
Share Price Value Today/Current/Last 8.68 Previous Day 8.70
Key Metrics
PE Ratio (x) | -202.61 | ||||||||||
EPS - TTM (₹) | -0.04 | ||||||||||
MCap (₹ Cr.) | 65.77 | ||||||||||
Sectoral MCap Rank | 33 | ||||||||||
PB Ratio (x) | 6.23 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| -0.50 | ||||||||||
VWAP (₹) | 8.52 | ||||||||||
52W H/L (₹) |
Transgene Biotek Share Price Returns
1 Day | -0.22% |
1 Week | -1.81% |
1 Month | -12.85% |
3 Months | 36.48% |
1 Year | 98.63% |
3 Years | 139.78% |
5 Years | 241.73% |
Transgene Biotek News & Analysis
Transgene Biotek Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Transgene Biotek Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
PAT: Entering the Green
Company has posted a profit of Rs 0.2 cr in Jun 30, 2024 quarter after 3 consecutive quarter of losses. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 80.33% outperformed its 3 year CAGR of -1.6%. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 0.70 0.10 0.09 0.09 0.14 Total Income Growth (%) 629.55 8.22 0.00 -38.22 227.84 Total Expenses 0.48 0.34 0.18 0.19 0.25 Total Expenses Growth (%) 44.12 91.40 -7.14 -24.43 -82.98 EBIT 0.22 -0.24 -0.09 -0.10 -0.11 EBIT Growth (%) - - - - - Profit after Tax (PAT) 0.20 -0.27 -0.12 -0.13 -0.14 PAT Growth (%) - - - - - EBIT Margin (%) 30.91 -249.74 -97.75 -112.95 -74.09 Net Profit Margin (%) 28.44 -283.35 -134.12 -149.32 -96.56 Basic EPS (₹) 0.03 -0.04 -0.02 -0.02 -0.02 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 142.33 142.36 147.10 156.88 166.75 Total Assets Growth (%) -0.02 -3.22 -6.24 -5.92 -5.55 Total Liabilities 131.62 130.99 129.72 134.64 134.08 Total Liabilities Growth (%) 0.48 0.98 -3.65 0.42 0.88 Total Equity 10.71 11.37 17.38 22.24 32.67 Total Equity Growth (%) -5.77 -34.58 -21.86 -31.94 -25.12 Current Ratio (x) 0.10 0.09 0.08 0.05 0.05 Total Debt to Equity (x) 1.31 1.15 0.69 0.51 0.32 Contingent Liabilities 0.00 0.99 0.99 0.99 0.99 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities -0.57 2,305.00 0.09 0.01 0.14 Net Cash used in Investing Activities -0.18 -0.01 -0.10 -0.03 - Net Cash flow from Financing Activities 0.75 - - - -0.20 Net Cash Flow 0.00 -0.01 -0.01 -0.01 -0.06 Closing Cash & Cash Equivalent 0.01 0.00 0.02 0.02 0.04 Closing Cash & Cash Equivalent Growth (%) 149.01 -79.82 -37.44 -38.00 -60.86 Total Debt/ CFO (x) -24.39 0.01 139.69 901.49 74.10 All figures in Rs Cr, unless mentioned otherwise
Insights
Losing Shareholder's Money
Company has reported a negative ROE for 3 consecutive years. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) -6.13 -52.85 -59.86 -46.92 -33.55 Return on Capital Employed (%) -0.40 -4.41 -7.37 -7.12 -6.91 Return on Assets (%) -0.46 -4.22 -7.07 -6.65 -6.57 Interest Coverage Ratio (x) -3.38 -4.84 -1.11 -38.19 -27.81 Asset Turnover Ratio (x) 0.00 0.00 0.00 0.10 0.00 Price to Earnings (x) -95.24 -3.14 -2.63 -3.33 -2.08 Price to Book (x) 5.76 1.66 1.57 1.56 0.70 EV/EBITDA (x) -173.60 -36.45 -156.30 -176.71 -48.33 EBITDA Margin (%) -187.16 -1,592.36 -290.36 -153.56 0.00
Transgene Biotek Peer Comparison
Transgene Biotek Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 142.54% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 142.54% return as compared to BSE Healthcare which gave investors 65.22% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 139.78% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 139.78% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Transgene Biotek Board Meeting/AGM
Transgene Biotek Dividends
- Others
Meeting Date Announced on Purpose Details Aug 10, 2024 Jul 19, 2024 Board Meeting Quarterly Results May 30, 2024 May 13, 2024 Board Meeting Audited Results Feb 14, 2024 Jan 29, 2024 Board Meeting Quarterly Results Dec 30, 2023 Nov 16, 2023 AGM A.G.M. Nov 14, 2023 Nov 06, 2023 Board Meeting Quarterly Results & Others Dividend announcements are not available.
All Types Ex-Date Record Date Announced on Details Rights - Feb 10, 1995 Apr 13, 1995 Rights ratio: 3 share for every 5 held at a price of Rs 30.0
About Transgene Biotek
Transgene Biotek Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 65.77 Crore) operating in Hospitals & Allied Services sector. Transgene Biotek Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2023. Show More
Executives
Auditors
- KK
K Koteswara Rao
Chairman & Managing DirectorSKSantosh Kumar
DirectorSKSujana Kadiam
DirectorSMSwetha Marri
DirectorShow More - Manisha Dubey & AssociatesLakshmi & Associates
Industry
Key Indices Listed on
-
Address
Plot Nos. 69 & 70,Anrich Industrial Area,IDA Bollaram,Sangareddy Dist., Telangana - 502325
More Details
FAQs about Transgene Biotek share
- 1. What is Transgene Biotek share price and what are the returns for Transgene Biotek share?Transgene Biotek share price was Rs 8.68 as on 29 Aug, 2024, 03:44 PM IST. Transgene Biotek share price was down by 0.22% based on previous share price of Rs 8.75. Transgene Biotek share price trend:
- Last 3 Months: Transgene Biotek share price moved up by 36.48%
- Last 12 Months: Transgene Biotek share price moved up 98.63%
- Last 3 Years: Transgene Biotek Share price moved up by 139.78%
- 2. What is the market cap of Transgene Biotek?Transgene Biotek share has a market capitalization of Rs 65.77 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 33.
- 3. What has been highest price of Transgene Biotek share in last 52 weeks?52 Week high of Transgene Biotek share is Rs 12.46 while 52 week low is Rs 3.84
- 4. What are the Transgene Biotek quarterly results?On Consoldiated basis, Transgene Biotek reported a total income and profit of Rs 0.70 Cr and Rs 0.20 respectively for quarter ending 2024-06-30. Total Income and loss for the year ending 2024-03-31 was Rs 0.42 Cr and Rs -0.66 Cr.
- 5. Who's the chairman of Transgene Biotek?K Koteswara Rao is the Chairman & Managing Director of Transgene Biotek
- 6. How can I quickly analyze Transgene Biotek stock?Key Metrics for Transgene Biotek are:
- PE Ratio of Transgene Biotek is -202.61
- Price/Sales ratio of Transgene Biotek is 271.33
- Price to Book ratio of Transgene Biotek is 6.23
- 7. Who are peers to compare Transgene Biotek share price?Top 10 Peers for Transgene Biotek are GKB Ophthalmics Ltd., Shree Pacetronix Ltd., Centenial Surgical Suture Ltd., Bandaram Pharma Packtech Ltd., Constronics Infra Ltd., Kretto Syscon Ltd., Span Divergent Ltd., Transpact Enterprises Ltd., Denis Chem Lab Ltd. and Nureca Ltd.
- 8. What is the CAGR of Transgene Biotek?The CAGR of Transgene Biotek is 8.26.
- 9. Who are the key owners of Transgene Biotek stock?Promoter owns 23.64, shares of Transgene Biotek as on 30 Jun 2024
- There is no change in promoter holding from 31 Mar 2024 to 30 Jun 2024
- There is no change in Other investor holding from 31 Mar 2024 to 30 Jun 2024
- 10. What is the PE & PB ratio of Transgene Biotek?The PE ratio of Transgene Biotek stands at -204.95, while the PB ratio is 6.21.
- 11. What are the returns for Transgene Biotek share?Return Performance of Transgene Biotek Shares:
- 1 Week: Transgene Biotek share price moved down by 1.81%
- 3 Month: Transgene Biotek share price moved up by 36.48%
- 6 Month: Transgene Biotek share price moved down by 16.62%
Trending in Markets
Transgene Biotek Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.